Ann M. Kim is an associate who focuses her practice on general corporate matters, including capital markets, venture capital financings, mergers and acquisitions, and securities law compliance.

Ann works with a variety of public and private clients, including tech companies and startups, primarily in the life sciences, digital health, artificial intelligence, SaaS, defensetech and cybersecurity sectors.

Representative Experience

  • Represented Epirus, a high-growth defense technology company, in its oversubscribed $250 million Series D financing.
  • Represented Bilt Rewards, the leading loyalty platform specializing in rent and neighborhood rewards, in its $150 million financing and $200 million financing, which increased its valuation to $3.1 billion.
  • Represented Nikola Corporation, an integrated truck and energy company transforming commercial transportation with its Class 8 vehicles, in its $275 million common stock and green convertible senior notes offerings and its $200 million common stock offering.

View More

  • Representative Mergers & Acquisitions Experience
    • Represented Identiv, Inc. in the $145 million sale of its physical security, access card, and identity reader operations and assets to Vitaprotech Group SAS.
    • Represented Qualer, Inc., a SaaS solution for asset management for life sciences lab equipment, in its acquisition by MasterControl Solutions, Inc.
    • Represented Normalyze, Inc., a data-first-cloud-security platform, in its acquisition by Proofpoint Inc.
    • Represented Adroit, a Medtech supplier, in its acquisition by Arterex.
    • Represented Bear Electrical Solutions, a provider of construction and maintenance services for traffic, street and parking signals, in its acquisition by Midwestern Electric, a portfolio company of CAI Capital Partners.
  • Representative Emerging Growth Experience
    • Represented Humaneva, Inc., a spin-off of Poland-based wholesale pharmaceutical distributor NEUCA S.A., in connection with its $50 million minority stake investment agreement with Viking Global Investors.
    • Represented Atmosic Technologies, a provider of ultra-low-power computer and connectivity solutions, in its $40 million funding round.
    • Represented Vasa Therapeutics Inc., a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging, in its $6 million Series Seed financing.
    • Represented Cercle, an AI-driven women’s health care insights platform company, in its $6 million Series Seed financing.
    • Represented Fudo Security, a cybersecurity firm, in its $10 million funding round.
    • Represented a technology platform company in its $6 million Series C-2 financing.
  • Representative Securities Offerings Experience
    • Represented Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company, in its $16.5 million public offering of common stock and warrants.
    • Represented Acer Therapeutics Inc., a leading pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, in its $2.675 million registered direct offering and concurrent private placement.
    • Represented Invitae Corporation, a leading medical genetics company, in its ATM equity offering.

Professional Highlights

  • Before law school, Ann worked at a startup in Sweden and at a large law firm in Los Angeles. During law school, she interned at a private fintech company and received the American Jurisprudence Award (First in Class) in Negotiations. Ann graduated with a business law certificate and pro bono honors.

Education

  • J.D., University of California, Berkeley School of Law (Berkeley Law), 2022
    Articles Editor, Berkeley Business Law Journal

    B.A., University of California, Berkeley, 2017
    Magna cum laude; Phi Beta Kappa

Admissions

  • California

Languages

  • Korean